Monitoring of high-density lipoprotein cholesterol level is predictive of EGFR mutation and efficacy of EGFR-TKI in patients with advanced lung adenocarcinoma

High-density lipoprotein cholesterol (HDL-C) has an inverse association with the incidence of lung cancer. However, whether it can be used as a predictive factor in advanced lung adenocarcinoma patients treated with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) still remai...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Yang, Miao, Li-Yun, Chen, Qiu-Fang, Li, Yan, Shi, Zhi-Xiang, Ding, Xuan-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730999/
https://www.ncbi.nlm.nih.gov/pubmed/26858527
http://dx.doi.org/10.2147/OTT.S96199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730999/
https://www.ncbi.nlm.nih.gov/pubmed/26858527
http://dx.doi.org/10.2147/OTT.S96199

Ejemplares similares